nodes	percent_of_prediction	percent_of_DWPC	metapath
Levetiracetam—ABCC2—Spironolactone—dilated cardiomyopathy	0.351	0.42	CbGbCtD
Levetiracetam—ABCC2—Furosemide—dilated cardiomyopathy	0.24	0.287	CbGbCtD
Levetiracetam—ABCB1—Lisinopril—dilated cardiomyopathy	0.13	0.156	CbGbCtD
Levetiracetam—ABCB1—Spironolactone—dilated cardiomyopathy	0.114	0.137	CbGbCtD
Levetiracetam—Common cold—Lisinopril—dilated cardiomyopathy	0.00543	0.033	CcSEcCtD
Levetiracetam—Hypersomnia—Lisinopril—dilated cardiomyopathy	0.00543	0.033	CcSEcCtD
Levetiracetam—Apathy—Furosemide—dilated cardiomyopathy	0.00265	0.0161	CcSEcCtD
Levetiracetam—Flat affect—Furosemide—dilated cardiomyopathy	0.00262	0.0159	CcSEcCtD
Levetiracetam—Lethargy—Spironolactone—dilated cardiomyopathy	0.00257	0.0156	CcSEcCtD
Levetiracetam—Ataxia—Spironolactone—dilated cardiomyopathy	0.00237	0.0144	CcSEcCtD
Levetiracetam—Toxic epidermal necrolysis—Spironolactone—dilated cardiomyopathy	0.00227	0.0138	CcSEcCtD
Levetiracetam—Disturbance in attention—Furosemide—dilated cardiomyopathy	0.00218	0.0132	CcSEcCtD
Levetiracetam—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.00216	0.0131	CcSEcCtD
Levetiracetam—Drug interaction—Furosemide—dilated cardiomyopathy	0.00204	0.0124	CcSEcCtD
Levetiracetam—Throat sore—Lisinopril—dilated cardiomyopathy	0.00197	0.0119	CcSEcCtD
Levetiracetam—Oropharyngeal discomfort—Lisinopril—dilated cardiomyopathy	0.00195	0.0118	CcSEcCtD
Levetiracetam—Drowsiness—Spironolactone—dilated cardiomyopathy	0.00194	0.0118	CcSEcCtD
Levetiracetam—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.00193	0.0117	CcSEcCtD
Levetiracetam—Otitis media—Lisinopril—dilated cardiomyopathy	0.00182	0.0111	CcSEcCtD
Levetiracetam—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.00181	0.011	CcSEcCtD
Levetiracetam—Memory impairment—Lisinopril—dilated cardiomyopathy	0.00181	0.011	CcSEcCtD
Levetiracetam—Rhinorrhoea—Lisinopril—dilated cardiomyopathy	0.00175	0.0106	CcSEcCtD
Levetiracetam—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.00165	0.01	CcSEcCtD
Levetiracetam—Mental disability—Furosemide—dilated cardiomyopathy	0.00164	0.00996	CcSEcCtD
Levetiracetam—Accidental injury—Lisinopril—dilated cardiomyopathy	0.0016	0.00973	CcSEcCtD
Levetiracetam—Viral infection—Lisinopril—dilated cardiomyopathy	0.00157	0.00953	CcSEcCtD
Levetiracetam—Oropharyngeal pain—Lisinopril—dilated cardiomyopathy	0.00156	0.00947	CcSEcCtD
Levetiracetam—Cough increased—Lisinopril—dilated cardiomyopathy	0.00155	0.00941	CcSEcCtD
Levetiracetam—Alopecia—Spironolactone—dilated cardiomyopathy	0.00154	0.00936	CcSEcCtD
Levetiracetam—Drug interaction—Lisinopril—dilated cardiomyopathy	0.00153	0.00928	CcSEcCtD
Levetiracetam—Dermatitis bullous—Furosemide—dilated cardiomyopathy	0.00144	0.00872	CcSEcCtD
Levetiracetam—Neck pain—Lisinopril—dilated cardiomyopathy	0.00144	0.00872	CcSEcCtD
Levetiracetam—Lethargy—Furosemide—dilated cardiomyopathy	0.0014	0.0085	CcSEcCtD
Levetiracetam—Hyponatraemia—Furosemide—dilated cardiomyopathy	0.00138	0.00836	CcSEcCtD
Levetiracetam—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00136	0.00825	CcSEcCtD
Levetiracetam—Irritability—Furosemide—dilated cardiomyopathy	0.00131	0.00795	CcSEcCtD
Levetiracetam—Dehydration—Furosemide—dilated cardiomyopathy	0.00128	0.00775	CcSEcCtD
Levetiracetam—Confusional state—Spironolactone—dilated cardiomyopathy	0.00125	0.00759	CcSEcCtD
Levetiracetam—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.00124	0.0075	CcSEcCtD
Levetiracetam—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00121	0.00737	CcSEcCtD
Levetiracetam—Muscular weakness—Furosemide—dilated cardiomyopathy	0.00121	0.00735	CcSEcCtD
Levetiracetam—Eosinophilia—Furosemide—dilated cardiomyopathy	0.00117	0.00713	CcSEcCtD
Levetiracetam—Pancreatitis—Furosemide—dilated cardiomyopathy	0.00116	0.00706	CcSEcCtD
Levetiracetam—Gastroenteritis—Lisinopril—dilated cardiomyopathy	0.00116	0.00705	CcSEcCtD
Levetiracetam—Eczema—Lisinopril—dilated cardiomyopathy	0.00115	0.00696	CcSEcCtD
Levetiracetam—Hepatic failure—Lisinopril—dilated cardiomyopathy	0.00115	0.00696	CcSEcCtD
Levetiracetam—Nasal congestion—Lisinopril—dilated cardiomyopathy	0.00113	0.00686	CcSEcCtD
Levetiracetam—Injury—Lisinopril—dilated cardiomyopathy	0.00112	0.0068	CcSEcCtD
Levetiracetam—Somnolence—Spironolactone—dilated cardiomyopathy	0.0011	0.00669	CcSEcCtD
Levetiracetam—Renal impairment—Lisinopril—dilated cardiomyopathy	0.00108	0.00657	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00107	0.0065	CcSEcCtD
Levetiracetam—Drowsiness—Furosemide—dilated cardiomyopathy	0.00106	0.00642	CcSEcCtD
Levetiracetam—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.00105	0.00637	CcSEcCtD
Levetiracetam—Hyponatraemia—Lisinopril—dilated cardiomyopathy	0.00103	0.00628	CcSEcCtD
Levetiracetam—Diplopia—Lisinopril—dilated cardiomyopathy	0.00103	0.00625	CcSEcCtD
Levetiracetam—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00102	0.0062	CcSEcCtD
Levetiracetam—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.001	0.00607	CcSEcCtD
Levetiracetam—Face oedema—Lisinopril—dilated cardiomyopathy	0.000994	0.00603	CcSEcCtD
Levetiracetam—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.000987	0.00599	CcSEcCtD
Levetiracetam—Irritability—Lisinopril—dilated cardiomyopathy	0.000983	0.00597	CcSEcCtD
Levetiracetam—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00098	0.00595	CcSEcCtD
Levetiracetam—Ataxia—Lisinopril—dilated cardiomyopathy	0.000968	0.00588	CcSEcCtD
Levetiracetam—Dehydration—Lisinopril—dilated cardiomyopathy	0.000957	0.00581	CcSEcCtD
Levetiracetam—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.000927	0.00563	CcSEcCtD
Levetiracetam—Nasopharyngitis—Lisinopril—dilated cardiomyopathy	0.000921	0.00559	CcSEcCtD
Levetiracetam—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.000913	0.00555	CcSEcCtD
Levetiracetam—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.000898	0.00545	CcSEcCtD
Levetiracetam—Influenza—Lisinopril—dilated cardiomyopathy	0.00089	0.0054	CcSEcCtD
Levetiracetam—Asthma—Lisinopril—dilated cardiomyopathy	0.00089	0.0054	CcSEcCtD
Levetiracetam—Eye disorder—Furosemide—dilated cardiomyopathy	0.000887	0.00539	CcSEcCtD
Levetiracetam—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.000881	0.00535	CcSEcCtD
Levetiracetam—Pruritus—Spironolactone—dilated cardiomyopathy	0.000877	0.00532	CcSEcCtD
Levetiracetam—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.000872	0.0053	CcSEcCtD
Levetiracetam—Immune system disorder—Furosemide—dilated cardiomyopathy	0.000857	0.00521	CcSEcCtD
Levetiracetam—Bronchitis—Lisinopril—dilated cardiomyopathy	0.000856	0.0052	CcSEcCtD
Levetiracetam—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000848	0.00515	CcSEcCtD
Levetiracetam—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.000845	0.00513	CcSEcCtD
Levetiracetam—Neutropenia—Lisinopril—dilated cardiomyopathy	0.000832	0.00505	CcSEcCtD
Levetiracetam—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.000827	0.00502	CcSEcCtD
Levetiracetam—Malnutrition—Furosemide—dilated cardiomyopathy	0.000826	0.00502	CcSEcCtD
Levetiracetam—Dizziness—Spironolactone—dilated cardiomyopathy	0.00082	0.00498	CcSEcCtD
Levetiracetam—Weight increased—Lisinopril—dilated cardiomyopathy	0.00081	0.00492	CcSEcCtD
Levetiracetam—Weight decreased—Lisinopril—dilated cardiomyopathy	0.000805	0.00489	CcSEcCtD
Levetiracetam—Depression—Lisinopril—dilated cardiomyopathy	0.000791	0.0048	CcSEcCtD
Levetiracetam—Vomiting—Spironolactone—dilated cardiomyopathy	0.000788	0.00479	CcSEcCtD
Levetiracetam—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.000787	0.00478	CcSEcCtD
Levetiracetam—Rash—Spironolactone—dilated cardiomyopathy	0.000782	0.00475	CcSEcCtD
Levetiracetam—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000781	0.00474	CcSEcCtD
Levetiracetam—Vision blurred—Furosemide—dilated cardiomyopathy	0.000779	0.00473	CcSEcCtD
Levetiracetam—Headache—Spironolactone—dilated cardiomyopathy	0.000777	0.00472	CcSEcCtD
Levetiracetam—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.000771	0.00468	CcSEcCtD
Levetiracetam—Agitation—Furosemide—dilated cardiomyopathy	0.000759	0.00461	CcSEcCtD
Levetiracetam—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.00075	0.00456	CcSEcCtD
Levetiracetam—Epistaxis—Lisinopril—dilated cardiomyopathy	0.000748	0.00454	CcSEcCtD
Levetiracetam—Sinusitis—Lisinopril—dilated cardiomyopathy	0.000744	0.00452	CcSEcCtD
Levetiracetam—Vertigo—Furosemide—dilated cardiomyopathy	0.000742	0.00451	CcSEcCtD
Levetiracetam—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.00074	0.0045	CcSEcCtD
Levetiracetam—Leukopenia—Furosemide—dilated cardiomyopathy	0.00074	0.00449	CcSEcCtD
Levetiracetam—Nausea—Spironolactone—dilated cardiomyopathy	0.000736	0.00447	CcSEcCtD
Levetiracetam—Rhinitis—Lisinopril—dilated cardiomyopathy	0.000714	0.00434	CcSEcCtD
Levetiracetam—Hepatitis—Lisinopril—dilated cardiomyopathy	0.000712	0.00432	CcSEcCtD
Levetiracetam—Hallucination—Lisinopril—dilated cardiomyopathy	0.000709	0.0043	CcSEcCtD
Levetiracetam—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.000707	0.00429	CcSEcCtD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.000699	0.00424	CcSEcCtD
Levetiracetam—Confusional state—Furosemide—dilated cardiomyopathy	0.00068	0.00413	CcSEcCtD
Levetiracetam—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.000673	0.00409	CcSEcCtD
Levetiracetam—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.000661	0.00402	CcSEcCtD
Levetiracetam—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00066	0.00401	CcSEcCtD
Levetiracetam—Skin disorder—Furosemide—dilated cardiomyopathy	0.000655	0.00398	CcSEcCtD
Levetiracetam—Anorexia—Furosemide—dilated cardiomyopathy	0.000643	0.0039	CcSEcCtD
Levetiracetam—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.000642	0.0039	CcSEcCtD
Levetiracetam—Alopecia—Lisinopril—dilated cardiomyopathy	0.000629	0.00382	CcSEcCtD
Levetiracetam—Mental disorder—Lisinopril—dilated cardiomyopathy	0.000624	0.00379	CcSEcCtD
Levetiracetam—Malnutrition—Lisinopril—dilated cardiomyopathy	0.00062	0.00376	CcSEcCtD
Levetiracetam—Tension—Lisinopril—dilated cardiomyopathy	0.000608	0.00369	CcSEcCtD
Levetiracetam—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000606	0.00368	CcSEcCtD
Levetiracetam—Nervousness—Lisinopril—dilated cardiomyopathy	0.000602	0.00366	CcSEcCtD
Levetiracetam—Back pain—Lisinopril—dilated cardiomyopathy	0.0006	0.00364	CcSEcCtD
Levetiracetam—Somnolence—Furosemide—dilated cardiomyopathy	0.0006	0.00364	CcSEcCtD
Levetiracetam—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000586	0.00356	CcSEcCtD
Levetiracetam—Vision blurred—Lisinopril—dilated cardiomyopathy	0.000584	0.00355	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000582	0.00354	CcSEcCtD
Levetiracetam—Fatigue—Furosemide—dilated cardiomyopathy	0.000581	0.00353	CcSEcCtD
Levetiracetam—Tremor—Lisinopril—dilated cardiomyopathy	0.000581	0.00353	CcSEcCtD
Levetiracetam—Pain—Furosemide—dilated cardiomyopathy	0.000577	0.0035	CcSEcCtD
Levetiracetam—Constipation—Furosemide—dilated cardiomyopathy	0.000577	0.0035	CcSEcCtD
Levetiracetam—Vertigo—Lisinopril—dilated cardiomyopathy	0.000557	0.00338	CcSEcCtD
Levetiracetam—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000556	0.00337	CcSEcCtD
Levetiracetam—Leukopenia—Lisinopril—dilated cardiomyopathy	0.000555	0.00337	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000551	0.00335	CcSEcCtD
Levetiracetam—Cough—Lisinopril—dilated cardiomyopathy	0.000541	0.00329	CcSEcCtD
Levetiracetam—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000533	0.00324	CcSEcCtD
Levetiracetam—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000533	0.00324	CcSEcCtD
Levetiracetam—Chest pain—Lisinopril—dilated cardiomyopathy	0.000528	0.0032	CcSEcCtD
Levetiracetam—Myalgia—Lisinopril—dilated cardiomyopathy	0.000528	0.0032	CcSEcCtD
Levetiracetam—Arthralgia—Lisinopril—dilated cardiomyopathy	0.000528	0.0032	CcSEcCtD
Levetiracetam—Anxiety—Lisinopril—dilated cardiomyopathy	0.000526	0.00319	CcSEcCtD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.000524	0.00318	CcSEcCtD
Levetiracetam—Confusional state—Lisinopril—dilated cardiomyopathy	0.00051	0.0031	CcSEcCtD
Levetiracetam—Infection—Lisinopril—dilated cardiomyopathy	0.000503	0.00305	CcSEcCtD
Levetiracetam—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000497	0.00302	CcSEcCtD
Levetiracetam—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000495	0.00301	CcSEcCtD
Levetiracetam—Skin disorder—Lisinopril—dilated cardiomyopathy	0.000491	0.00298	CcSEcCtD
Levetiracetam—Asthenia—Furosemide—dilated cardiomyopathy	0.000484	0.00294	CcSEcCtD
Levetiracetam—Anorexia—Lisinopril—dilated cardiomyopathy	0.000482	0.00293	CcSEcCtD
Levetiracetam—Pruritus—Furosemide—dilated cardiomyopathy	0.000477	0.0029	CcSEcCtD
Levetiracetam—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000461	0.0028	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000461	0.0028	CcSEcCtD
Levetiracetam—Insomnia—Lisinopril—dilated cardiomyopathy	0.000458	0.00278	CcSEcCtD
Levetiracetam—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000454	0.00276	CcSEcCtD
Levetiracetam—Somnolence—Lisinopril—dilated cardiomyopathy	0.00045	0.00273	CcSEcCtD
Levetiracetam—Dizziness—Furosemide—dilated cardiomyopathy	0.000446	0.00271	CcSEcCtD
Levetiracetam—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000445	0.0027	CcSEcCtD
Levetiracetam—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00044	0.00267	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000437	0.00265	CcSEcCtD
Levetiracetam—Fatigue—Lisinopril—dilated cardiomyopathy	0.000436	0.00265	CcSEcCtD
Levetiracetam—Pain—Lisinopril—dilated cardiomyopathy	0.000433	0.00263	CcSEcCtD
Levetiracetam—Constipation—Lisinopril—dilated cardiomyopathy	0.000433	0.00263	CcSEcCtD
Levetiracetam—Vomiting—Furosemide—dilated cardiomyopathy	0.000429	0.0026	CcSEcCtD
Levetiracetam—Rash—Furosemide—dilated cardiomyopathy	0.000425	0.00258	CcSEcCtD
Levetiracetam—Dermatitis—Furosemide—dilated cardiomyopathy	0.000425	0.00258	CcSEcCtD
Levetiracetam—Headache—Furosemide—dilated cardiomyopathy	0.000422	0.00257	CcSEcCtD
Levetiracetam—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000417	0.00253	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000414	0.00251	CcSEcCtD
Levetiracetam—Nausea—Furosemide—dilated cardiomyopathy	0.000401	0.00243	CcSEcCtD
Levetiracetam—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.0004	0.00243	CcSEcCtD
Levetiracetam—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.0004	0.00243	CcSEcCtD
Levetiracetam—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000373	0.00226	CcSEcCtD
Levetiracetam—Asthenia—Lisinopril—dilated cardiomyopathy	0.000363	0.0022	CcSEcCtD
Levetiracetam—Pruritus—Lisinopril—dilated cardiomyopathy	0.000358	0.00217	CcSEcCtD
Levetiracetam—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000346	0.0021	CcSEcCtD
Levetiracetam—Dizziness—Lisinopril—dilated cardiomyopathy	0.000335	0.00203	CcSEcCtD
Levetiracetam—Vomiting—Lisinopril—dilated cardiomyopathy	0.000322	0.00195	CcSEcCtD
Levetiracetam—Rash—Lisinopril—dilated cardiomyopathy	0.000319	0.00194	CcSEcCtD
Levetiracetam—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000319	0.00194	CcSEcCtD
Levetiracetam—Headache—Lisinopril—dilated cardiomyopathy	0.000317	0.00192	CcSEcCtD
Levetiracetam—Nausea—Lisinopril—dilated cardiomyopathy	0.000301	0.00182	CcSEcCtD
